GHRP-6 vs Sermorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
GHRP-6 is the original growth hormone releasing peptide, discovered by Cyril Bowers in the 1970s through systematic study of enkephalin analogs. It was the first molecule to reveal the existence of the ghrelin receptor pathway, predating the discovery of ghrelin itself....
Calculate GHRP-6 dose →Sermorelin is a synthetic analog of the first 29 amino acids of endogenous GHRH, retaining full biological activity at the GHRH receptor. It was FDA approved (Geref) for GH deficiency in children from 1997 until its voluntary market withdrawal in 2008 for commercial reasons - not...
Calculate Sermorelin dose →| Parameter | GHRP-6 | Sermorelin |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | ~15–60 min | ~10–20 min |
| Typical Dose | 100–300 µg | 200–500 µg |
| Frequency | 2–3× daily | Once daily (bedtime) |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Compounding Only |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.